Effect of allergen immunotherapy on nasal responses in guinea-pigs with allergic rhinitis

Clinical and Experimental Allergy

Volumn 27, Issue 9, 1997, Pages 1103-1108

  Nakamoto, S ^a   Ukai, K ^a   Sakakura, Y ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Allergen immunotherapy; Allergic rhinitis; Dye leakage; Guinea pigs; Mast cell; Ovalbumin

Indexed keywords

ALLERGEN; HISTAMINE; OVALBUMIN;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; GUINEA PIG; IMMUNOLOGICAL TOLERANCE; INTRADERMAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAST CELL; NONHUMAN; NOSE MUCOSA; POLLEN ALLERGY; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; ALLERGENS; ANIMALS; COLORING AGENTS; DESENSITIZATION, IMMUNOLOGIC; GUINEA PIGS; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INJECTIONS, INTRADERMAL; MALE; MAST CELLS; NASAL MUCOSA; OVALBUMIN; RHINITIS, ALLERGIC, PERENNIAL; SKIN;

EID: 0030879778     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb01263.x     Document Type: Article

References (28)

1. Noon L, Cantab BC. Prophylactic inoculation against hay fever. Lancet 1911; i: 1572-3.
2. Bousquet J, Hejjaoui A, Michel FB. Specific immunotherapy in asthma. J Allergy Clin Immunol 1990; 86:292-306.
3. Committee on safety of medicines. Desensitizing vaccines. Br Med J 1986; 293:948.
4. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing. J Allergy Clin Immunol 1987; 79:660-77.
5. Norman PS. Fatal misadventures. J Allergy Clin Immunol 1987; 79:572-3.
6. Lichtenstein LM, Norman PS, Winkenwerder WL. Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever. Am J Med 1968; 44:514-24.
7. Norman PS, Winkenwerder WL, Lichtenstein LM. Immunotherapy of hay fever with ragweed antigen E. comparisons with whole extracts and placebo. J Allergy 1968: 42:93-108.
8. Norman PS, Lichtenstein LM. Comparison of alum-precipitated and unprecipitated aqueous ragweed pollen extracts in the treatment of hay fever. J Allergy Clin Immunol 1978; 61:3849.
9. Ishida M, Amesara R, Ukai K, Sakakura Y. Antigen (DNP-As) -induced allergic rhinitis model in guinea pigs. Ann Allergy 1994; 72:240-4.
10. Ukai K, Yuda A, Nonoyama T, Sakakura Y. Effect of amlexanox on experimental allergic rhinitis in active sensitized guinea pigs. Jpn J Allergol 1987; 39:54-8.
11. Kawaguchi S, Majima Y, Sakakura Y. Nasal mast cells in experimental induced allergic rhinitis in guinea pigs. Clin Exp Allergy 1994; 24:238-44.
12. Ukai K, Amesara R, Sakakura Y. Nasal hypersensitivity and reactivity to histamine in guinea pig. Jpn J Allergol 1987; 36:386-93.
13. Ovary Z, Kaplan B, Kojima S. Characteristic of guinea pig IgE. Int Archs Allergy Appl Immunol 1976; 51:416-28.
14. Lange S, Nygren H, Svennerhorm AM, Holmgren J. Antitoxic cholera immunity in mice: influence of antigen deposition on antitoxin-containing cells and protective immunity in different parts of the intestine. Infect Immunity 1980; 28:17-23.
15. Lichtenstein LM, Holtzman NA, Burnett LS. A quantitative in vitro study of the Chromatographie distribution and immunoglobulin characteristics of human blocking antibody. J Immunol 1968; 101:317-24.
16. Van der Giessen M, Homan WL, Van Kernbeek G, Aalberse RC, Dieges PH. Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy. Int Archs Allergy Appl Immunol 1976; 50:625-40.
17. Nakagawa T, Takashi T, Sakamoto Y et al. IgG4 antibodies in patients with house-dust-mite sensitive bronchial asthma: relationship with antigen-specific immunotherapy. Int Archs Allergy Appl Immunol 1983; 71:122-5.
18. Van der Zee JS, Aalberse RC. The role of IgG. In (Lessof MH, Lee TH, Kemeny DM, eds) An International Textbook. Bath: John Wiley 1987:49-68.
19. NakagawaT. The role of IgG subclass antibodies in the clinical response to immunotherapy in allergic disease. Clin Exp Allergy 1991; 21:289-96.
20. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decrease Interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993; 178:2123-30.
21. Del Prête G, Maggi E, Parronchi P et al. IL-4 is an essential cofactor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988; 140:4193-8.
22. Juniper EF, O'Connor J, Roberts RS et al. Polyethylene glycolmodified ragweed extract: comparison of two treatment regimens. J Allergy Clin Immunol 1986; 78:851-6.
23. Hedlin G, Silber G, Schicken L et al. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol 1989; 84:390-9.
24. Kaise T, Ohmori K, Ukai K, Sakakura Y. Effect of oxatomide nasal spray on experimental allergic rhinitis in guinea pigs and rats. Int Arch Allergy Immunol 1995; 107:576-80.
25. Otsuka H, Mesawa A, Ohnishi M et al. Changes in nasal metachromatic cells during allergen immunotherapy. Clin Exp Allergy 1991; 21:115-9.
26. Pruzansky JJ, Patterson R. Histamine release from leukocytes of hypersensitive individuals. II. Reduced sensitivity of leukocytes after injection therapy. J Allergy 1967; 38:44-50.
27. Takagi M, Nakahata T, Kubo T et al. Stimulation of connective tissue type mast cells by hematopoietic stem cell factor, a ligand for the Cikit receptor. J Immunol 1992; 148:3446-53.
28. Beck LA, Schall TJ, Beall LD et al. Detection of chemokine RANTES and activation of vascular endothelium in nasal polyps. J Allergy Clin Immunol 1994; 93:234 (abst).